|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
Genius Group Updated 2024 Financial Guidance: $105 million to $110 million revenue with $6.0 million to $7.0 million positive EBITDA
Genius Group (NYSE American: GNS), a leading AI-powered education group, provided updated financial guidance for the financial year ending December 31, 2024. The updated guidance is over 100% higher than previously issued guidance as a result of the Company’s expansion in operations following a series of recent transactions. The Company also has an accelerated go-to-market strategy based on its Genius City Model, which enables the Company to grow its AI education courses and acceleration offerings city-by-city, via four revenue streams: students, entrepreneurs, enterprises and government.
2024 Updated Financial Guidance:
- Annual pro forma 2024 revenue of $105 million - $110 million, an 83% increase from the previous 2024 revenue guidance of $58 million - $60 million guidance.
- Pro forma 2024 Adjusted EBITDA of $6.0 million - $7.0 million, a 133% increase from the previous 2024 Adjusted EBITDA guidance of $2.5 million - $3.0 million.
- Number of students (and users) of 11.5 million to 12 million.
|
|
|
|
LOBO EV Technologies Ltd. Announces Pricing of Initial Public Offering and Listing on Nasdaq
LOBO EV Technologies Ltd. (Nasdaq: LOBO), an innovative electric vehicle manufacturer and seller, announced the pricing of its initial public offering of 1,380,000 ordinary shares, at a public offering price of $4.00 per share. Gross proceeds of the offering, prior to deducting underwriting discounts, commissions and offering expenses payable by the Company, are expected to be approximately $5.5 million. In addition, LOBO has granted the underwriters a 45-day option to purchase an additional 207,000 ordinary shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments. The shares began trading on the Nasdaq Capital Market on March 21, 2024 under the ticker symbol “LOBO.”
|
|
|
|
|
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Zomedica (NYSE American: ZOM), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Monday, April 1, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its fourth quarter and full year ended December 31, 2023. A question-and-answer session will follow management's prepared remarks.
|
|
|
|
|
|
|
Mobilicom to Showcase its Field-Proven Cybersecure Drone Solutions at the Association of the U.S. Army’s Annual Global Force Symposium & Expo
Mobilicom (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, today announced it will showcase its end-to-end solutions to procurement specialists from the U.S. Army and to defense contractors at the Association of the United States Army’s (AUSA) Global Force Symposium & Exposition in Huntsville, Alabama from March 26-28, 2024.
|
|
|
|
|
American Resources Corporation's ReElement Technologies Appoints His Excellency Baba Kamara to Board of Directors of ReElement Technologies Africa Ltd. Subsidiary
American Resources Corporation's (Nasdaq: AREC) wholly owned subsidiary, ReElement Technologies Corporation, a leading provider of high performance refining capacity of rare earth and critical battery elements, announced that its wholly owned subsidiary, ReElement Technologies Africa Ltd., has appointed His Excellency Baba Kamara to its Board of Directors as its first independent member of the African subsidiary. H.E. Kamara will act in his individual capacity to help guide the Company via its partnerships within Africa to ensure that the partnerships are established with a long-term, mutual benefit for all parties involved.
|
|
|
|
|
|
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
|
|
|
|
Upcoming Events
|
|
|
NASDAQ: XELB - Xcel Brands
4:15pm Eastern
Xcel Brands is a media and consumer products company engaged in the design, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as social commerce.
|
|
|
|
NASDAQ: LYT - Lytus Technologies
4:15pm Eastern
Lytus is a rapidly growing Platform IT services company. It currently has over 4 million active viewers and users in India.
|
|
|
|
Archived Events
|
|
|
NASDAQ: ASPI - ASP Isotopes
4:15pm Eastern
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries.
|
|
|
|
NASDAQ: ENLV - Enlivex Therapeutics
11:00am Eastern
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses.
|
|
|
|
NYSE: UMAC - Unusual Machines
4:15pm Eastern
Unusual Machines is focused on becoming a first-person view (FPV) drone technology market leader.
|
|
|
|
Quote of the Week
|
"Analysts can't serve two masters, so they joke that they work 75 percent of their time for investors and 75 percent of the time for corporate clients. But unbeknown to most small investors, the coporate client has won out. Today, it's common for analysts to offer to "provide coverage,"—code for positive coverage—in exchange for a corporate financing deal."
|
|
|
— Arthur Levitt, Take on the Street
|
|
|
|
|
RedChip TV
|
|
|
|
RedChip TV Highlights Mobilicom Limited (NASDAQ : MOB) & Lytus Technologies (NASDAQ: LYT) This Week
|
|
|
|
|
|
Enlivex's (NASDAQ:ENLV) Allocetra™: Breakthrough Macrophage Reprogramming Therapy
|
|
|
|
|
|
Unusual Machines: Revolutionizing the Drone Industry Through Strategic Growth and Innovation!
|
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
What insider buying may tell us about a stock.
|
|
|
|
|
|
MidSouth Week in Review
Housing stats were up 10.7% in February vs. January. Gold hit $2.25 before declining to $2.18.
|
|
|
|
|
|
|
|
